Potential Impact of Weight Reduction on Obesity-Related Complications

Overview

How weight reduction may mitigate obesity-related complications

This Class for

• Physician
• Resident / Fellow

What I will learn?

• Learn how achieving weight reduction may mitigate progress of many obesity-related complication
  
  
  
  
  Disclaimer
  
  This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
  (This information/content is intended to Health Care Providers only)
  
  For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
  24 /7 mobile : +966 567 868 843 working hours: +966 11 461 7800 , Ext: 1
  For Lilly product information: email: SAUDI_MEDINFOQUERIES@lilly.com
  For further information, please contact:
  Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: Saudi_Pharmacovigilance@lilly.com
  
  
  PP-LD-SA-0465

Related Classes

• Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin
• Second generation basal insulin in advancing T2D therapy
• Soliqua and Unmet Needs Webinar Summary - William Polonsky and Kathrine
• Timely insulin initiation to limit disease progression
• SURMOUNT-5 Clinical Update–Now Published
• Bridging pathophysiology and epidemiology for better understanding of obesity
• Introducing Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist
• Supporting Patients with Obesity Through Comprehensive Treatment